DefinitionThis section has been translated automatically.
The Angioedema Activity Score (AAS) is recommended by the EAACI/GA2LEN/EDF/WAO guidelines for urticaria as a standard measure for assessing disease activity in patients with recurrent angioedema. To date, it has been translated into 80 languages and used in 52 countries. It refers to a patient record by which activity and duration of angioedema is recorded and thus apparent to the physician providing care.
General informationThis section has been translated automatically.
Have you had any swelling in the last 24 hours?
During what period(s) did the swelling(s) exist? (please select all periods that apply)
- 0 - 8 o'clock
- 8 - 16 o'clock
- 16 - 24 o'clock
How severe are or were the physical discomforts (e.g., pain, burning, itching) caused by the swelling(s)?
Can or have you been able to perform your daily activities due to the current swelling(s)?
- no restriction
- slight restriction
- medium restriction
- Activities not possible
Do you feel or did you feel cosmetically affected by the current swelling(s)?
Overall, how severe would you rate the current swelling?
LiteratureThis section has been translated automatically.
- Kulthanan K et al (2019) Angioedema Activity Score (AAS): A Valid and Reliable Tool to Use in Asian Patients. Biomed Res Int 9157895.
- Morioke S et al (2021) A validation study of the Japanese version of the Angioedema Activity Score (AAS) and the Angioedema Quality of Life Questionnaire (AE-QoL). Allergol Int 70:471-479.